日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Population Pharmacokinetics of Atogepant for the Prevention of Migraine

阿托格泮预防偏头痛的群体药代动力学

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01566-5
Schlachter, Louisa; Stodtmann, Sven; Voelkner, Alexander; Jonsson, Fredrik; Lagraauw, Hendrik Maxime; Boinpally, Ramesh R
偏头痛
神经科学
发表日期：2026
文献求助 收藏

Predictive AI in Clinical Pharmacology: A Call to Action to Develop Robust Benchmarking Practices

临床药理学中的预测性人工智能：呼吁建立稳健的基准测试实践

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70155
Ponce-Bobadilla, Ana Victoria; Bräm, Dominic; Farnoud, Ali; Fröhlich, Holger; Janssen, Alexander; Korsbo, Niklas; Lindauer, Klaus; Raimúndez, Elba; Saini, Anuraag; Stodtmann, Sven; Valderrama, Diego; Balling, Kristoffer Winther; Knöchel, Jane; Mensing, Sven
发表日期：2026
文献求助 收藏

Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic Migraine

基于每月偏头痛天数的暴露-反应模型评估阿托格泮治疗发作性或慢性偏头痛患者的疗效

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70154
Schlachter, Louisa; Beck, Denise; Boinpally, Ramesh R; Stodtmann, Sven
偏头痛
神经科学
发表日期：2026
文献求助 收藏

Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's Disease

利用基于模型的荟萃分析指导阿尔茨海默病抗β-淀粉样蛋白疗法的早期临床试验设计

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70038
Bachhav, Sagar S; Ponce-Bobadilla, Ana Victoria; Clausznitzer, Diana; Stodtmann, Sven; Xiong, Hao
阿尔茨海默症
发表日期：2025
文献求助 收藏

Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development

基于模型的药物研发范式——以乌帕替尼研发为例的端到端案例研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70295
Bhatnagar, Sumit; Stodtmann, Sven; Qian, Yuli; Marroum, Patrick; Liu, Wei; Mohamed, Mohamed-Eslam F
发表日期：2025
文献求助 收藏

Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK models

将机器学习与药代动力学模型相结合：在现有药代动力学模型中添加神经网络组件，发挥科学机器学习的优势

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13054
Valderrama, Diego; Ponce-Bobadilla, Ana Victoria; Mensing, Sven; Fröhlich, Holger; Stodtmann, Sven
发表日期：2024
文献求助 收藏

Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development

SHAP 分析实用指南：解释药物研发中监督式机器学习模型的预测

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70056
Ponce-Bobadilla, Ana Victoria; Schmitt, Vanessa; Maier, Corinna S; Mensing, Sven; Stodtmann, Sven
发表日期：2024
文献求助 收藏

Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis

针对中轴型脊柱关节炎患者，对乌帕替尼进行群体药代动力学和暴露-反应分析，以评估其疗效和安全性

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13733
Bhatnagar, Sumit; Eckert, Doerthe; Stodtmann, Sven; Song, In-Ho; Wung, Peter; Liu, Wei; Mohamed, Mohamed-Eslam F
关节炎
发表日期：2024
文献求助 收藏

Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients

乌帕替尼在溃疡性结肠炎患者中的群体药代动力学和暴露-反应关系

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-022-01191-6
Ponce-Bobadilla, Ana Victoria; Stodtmann, Sven; Eckert, Doerthe; Zhou, Wen; Liu, Wei; Mohamed, Mohamed-Eslam F
结肠炎
肠炎
发表日期：2023
文献求助 收藏

Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis

利用elagolix治疗子宫内膜异位症女性的3期临床试验数据验证钙稳态定量系统药理学模型

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13040
Stodtmann, Sven; Nader, Ahmed; Polepally, Akshanth R; Suleiman, Ahmed A; Winzenborg, Insa; Noertersheuser, Peter; Ng, Juki; Mostafa, Nael M; Shebley, Mohamad
发表日期：2021
文献求助 收藏